Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Eapen

Showing results (21-30 of 208) with videos related to

Pageof 21
Sort By:
Seminars in Hematology|January 30, 2010
Transplant outcomes in acute leukemia. IMary Eapen, John E Wagner
Cytotherapy|June 8, 2026
Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapyMary Eapen, David A Williams
Best Practice & Research. Clinical Haematology|March 15, 2024
Corrigendum to "Endpoint selection and evaluation in hematology studies" [Best Pract Res Clin Haematol 36 (2023) 101479]Ruta Brazauskas, Mary Eapen, Tao Wang
Best Practice & Research. Clinical Haematology|August 23, 2023
Endpoint selection and evaluation in hematology studiesRuta Brazauskas, Mary Eapen, Tao Wang
The New England Journal of Medicine|January 15, 2015
One-unit versus two-unit cord-blood transplantationJohn E Wagner, Mary Eapen, Joanne Kurtzberg
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2012
HCT for nonmalignant disordersJohn F Tisdale, Mary Eapen, Riccardo Saccardi
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2020
The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort StudyGemlyn George, Andrew St Martin, Saurabh Chhabra, et al.
Clinical & Translational Immunology|April 15, 2026
Spatial omics for profiling the dynamic tumor microenvironmentHao Nguyen, Merrin Mary Eapen, Quan Nguyen, et al.
Blood|January 16, 2010
Acid sphingomyelinase deficiency does not protect from graft-versus-host disease in transplant recipients with Niemann-Pick diseaseJakub Tolar, Mary Eapen, Paul J Orchard, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 11, 2024
Navigating Treatment Options and Communication in Relapsed Pediatric AMLZachary Graff, Franziska Wachter, Mary Eapen, et al.
Pageof 21

Showing results (21-30 of 208) with videos related to

Sort By:
Pageof 21
Seminars in Hematology|January 30, 2010
Transplant outcomes in acute leukemia. IMary Eapen, John E Wagner
Cytotherapy|June 8, 2026
Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapyMary Eapen, David A Williams
Best Practice & Research. Clinical Haematology|March 15, 2024
Corrigendum to "Endpoint selection and evaluation in hematology studies" [Best Pract Res Clin Haematol 36 (2023) 101479]Ruta Brazauskas, Mary Eapen, Tao Wang
Best Practice & Research. Clinical Haematology|August 23, 2023
Endpoint selection and evaluation in hematology studiesRuta Brazauskas, Mary Eapen, Tao Wang
The New England Journal of Medicine|January 15, 2015
One-unit versus two-unit cord-blood transplantationJohn E Wagner, Mary Eapen, Joanne Kurtzberg
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2012
HCT for nonmalignant disordersJohn F Tisdale, Mary Eapen, Riccardo Saccardi
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2020
The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort StudyGemlyn George, Andrew St Martin, Saurabh Chhabra, et al.
Clinical & Translational Immunology|April 15, 2026
Spatial omics for profiling the dynamic tumor microenvironmentHao Nguyen, Merrin Mary Eapen, Quan Nguyen, et al.
Blood|January 16, 2010
Acid sphingomyelinase deficiency does not protect from graft-versus-host disease in transplant recipients with Niemann-Pick diseaseJakub Tolar, Mary Eapen, Paul J Orchard, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 11, 2024
Navigating Treatment Options and Communication in Relapsed Pediatric AMLZachary Graff, Franziska Wachter, Mary Eapen, et al.
Pageof 21